BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
| 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | |
|---|---|---|---|---|---|
| Revenue | -43.81% | -45.89% | -41.05% | -36.67% | -31.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -43.81% | -45.89% | -41.05% | -36.67% | -31.57% |
| Cost of Revenue | -47.02% | -42.59% | -36.86% | -33.59% | -31.25% |
| Gross Profit | -42.14% | -47.42% | -43.01% | -38.18% | -31.74% |
| SG&A Expenses | -40.00% | -44.83% | -44.29% | -49.22% | -51.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.03% | -37.28% | -37.34% | -43.33% | -47.17% |
| Operating Income | 34.32% | 33.34% | 35.80% | 45.60% | 51.59% |
| Income Before Tax | 34.26% | 34.10% | 28.69% | 42.66% | 49.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.26% | 34.10% | 28.69% | 42.66% | 49.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.26% | 34.10% | 28.69% | 42.66% | 49.11% |
| EBIT | 34.32% | 33.34% | 35.80% | 45.60% | 51.59% |
| EBITDA | 34.33% | 33.42% | 35.33% | 45.52% | 51.57% |
| EPS Basic | 25.84% | 27.89% | 39.98% | 53.49% | 57.58% |
| Normalized Basic EPS | 39.70% | 39.87% | 43.41% | 56.07% | 58.66% |
| EPS Diluted | 25.84% | 27.89% | 39.98% | 53.49% | 57.58% |
| Normalized Diluted EPS | 39.70% | 39.87% | 43.41% | 56.07% | 58.66% |
| Average Basic Shares Outstanding | 17.57% | 15.22% | 17.30% | 23.25% | 20.13% |
| Average Diluted Shares Outstanding | 17.57% | 15.22% | 17.30% | 23.25% | 20.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
